)

UroGen Pharma (URGN) investor relations material
UroGen Pharma H.C. Wainwright 27th Annual Global Investment Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Company overview and technology
Developed RTGel technology enabling sustained drug delivery in the urinary tract, transforming treatment for urothelial cancers.
First product, Jelmyto, approved in 2020 for low-grade upper tract urothelial cancer, offering a kidney-sparing alternative to surgery.
Zosduri (UGN-102) approved by FDA in June for low-grade intermediate risk non-muscle invasive bladder cancer, targeting a much larger patient population.
Market opportunity and launch progress
Zosduri targets 60,000 U.S. patients annually, representing a $5 billion+ market opportunity.
Sales force expanded from 52 to 82 reps post-approval, now covering 8,500 physicians and 90% of the target market.
Early launch shows high physician enthusiasm, strong initial demand, and broad market access with 90% of covered lives.
Several hundred sites activated to order and administer Zosduri, with robust patient enrollment forms received.
Clinical data and patient impact
Zosduri is the first and only FDA-approved non-surgical therapy for its indication, with 80% complete response at three months and 72% at 24 months.
Enables office-based, ambulatory treatment, highly preferred by patients over traditional surgery.
High patient and physician satisfaction, with 90% of surveyed patients preferring Zosduri to surgery.
Next UroGen Pharma earnings date

Next UroGen Pharma earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage